» Articles » PMID: 33015179

Identification of Key Genes in Gastric Cancer by Bioinformatics Analysis

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2020 Oct 5
PMID 33015179
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer (GC) is one of the most common malignancies of the digestive system with few genetic markers for its early detection and prevention. In this study, differentially expressed genes (DEGs) were analyzed using GEO2R from GSE54129 and GSE13911 of the Gene Expression Omnibus (GEO). Then, gene enrichment analysis, protein-protein interaction (PPI) network construction, and topological analysis were performed on the DEGs by the Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, STRING, and Cytoscape. Finally, we performed survival analysis of key genes through the Kaplan-Meier plotter. A total of 1034 DEGs were identified in GC. GO and KEGG results showed that DEGs mainly enriched in plasma membrane, cell adhesion, and PI3K-Akt signaling pathway. Subsequently, the PPI network with 44 nodes and 333 edges was constructed, and 18 candidate genes in the network were focused on by centrality analysis and module analysis. Furthermore, data showed that high expressions of fibronectin 1(FN1), the tissue inhibitor of metalloproteinases 1 (TIMP1), secreted phosphoprotein 1 (SPP1), apolipoprotein E (APOE), and versican (VCAN) were related to poor overall survivals in GC patients. In summary, this study suggests that FN1, TIMP1, SPP1, APOE, and VCAN may act as the key genes in GC.

Citing Articles

CTGF, FN1, IL-6, THBS1, and WISP1 genes and PI3K-Akt signaling pathway as prognostic and therapeutic targets in gastric cancer identified by gene network modeling.

Khoshdel F, Mottaghi-Dastjerdi N, Yazdani F, Salehi S, Ghorbani A, Montazeri H Discov Oncol. 2024; 15(1):344.

PMID: 39133458 PMC: 11319544. DOI: 10.1007/s12672-024-01225-4.


Novel chromium (III)-based compound for inhibition of oxaliplatin-resistant colorectal cancer progression.

Chen M, Devi H, Pien H, Wen S, Sheu J, Tsai B Am J Cancer Res. 2024; 14(3):979-995.

PMID: 38590406 PMC: 10998745. DOI: 10.62347/XTRT2780.


Development and verification of a newly established cuproptosis-associated lncRNA model for predicting overall survival in uterine corpus endometrial carcinoma.

Hu P, Wang Y, Chen X, Zhao L, Qi C, Jiang G Transl Cancer Res. 2023; 12(8):1963-1979.

PMID: 37701111 PMC: 10493807. DOI: 10.21037/tcr-23-61.


DLC1 as Druggable Target for Specific Subsets of Gastric Cancer: An RNA-seq-Based Study.

Yang L, Bhat A, Qazi S, Raza K Medicina (Kaunas). 2023; 59(3).

PMID: 36984515 PMC: 10056469. DOI: 10.3390/medicina59030514.


Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing.

Mosharaf M, Kibria M, Hossen M, Islam M, Reza M, Mahumud R Vaccines (Basel). 2022; 10(8).

PMID: 36016137 PMC: 9415433. DOI: 10.3390/vaccines10081248.


References
1.
Karimi P, Islami F, Anandasabapathy S, Freedman N, Kamangar F . Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014; 23(5):700-13. PMC: 4019373. DOI: 10.1158/1055-9965.EPI-13-1057. View

2.
Kwiatkowski P, Wierzbicki P, Kmiec A, Godlewski J . [DNA microarray-based gene expression profiling in diagnosis, assessing prognosis and predicting response to therapy in colorectal cancer]. Postepy Hig Med Dosw (Online). 2012; 66:330-8. DOI: 10.5604/17322693.999919. View

3.
Pan J, Zhou H, Cooper L, Huang J, Zhu S, Zhao X . LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Front Immunol. 2019; 10:6. PMC: 6362421. DOI: 10.3389/fimmu.2019.00006. View

4.
Chen T, Sun L, He C, Gong Y, Xu Q, Yuan Y . Serum OPN expression for identification of gastric cancer and atrophic gastritis and its influencing factors. PLoS One. 2014; 9(12):e114005. PMC: 4257596. DOI: 10.1371/journal.pone.0114005. View

5.
Abedi M, Gheisari Y . Nodes with high centrality in protein interaction networks are responsible for driving signaling pathways in diabetic nephropathy. PeerJ. 2015; 3:e1284. PMC: 4636410. DOI: 10.7717/peerj.1284. View